Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zou, Constance X.
Becker, Jessica E.
Phillips, Adam T.
Garritano, James M.
Krumholz, Harlan M.
Miller, Jennifer E.
Ross, Joseph S.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (T35HL007649)